The Evolution of Robotic Mitral Valve Surgery at the Cleveland Clinic (Video)
World's Largest Resource for Cardiovascular Perfusion
We propose a periosteal substitute engineered using a platelet rich plasma (PRP) membrane incorporating autologous bone marrow derived mesenchymal stem cells (PRP/BMSC gel membrane) to be wrapped around an osteoconductive scaffold for regeneration of compromised bone defects.
For perfusionists, few moments carry as much weight as sitting for a certification exam that can shape the trajectory of an entire career. The Perfusion Certification Examination Prep Course by Perfusion.com was created to ease that pressure, transforming uncertainty into structured preparation and confidence. Developed with insight from educators and practicing clinicians, the course is designed not just as a study aid, but as a professional safety net. At the center of its development is veteran perfusionist and educator Ben Greenfield, whose vision helped shape the course into a resource with worldwide impact.
Terumo Americas Holding, Inc., a U.S. subsidiary of Japan’s Terumo Corporation, one of the world’s leading medical device manufacturers with $3.4 billion in sales and operations in more than 160 nations, today announced that it has entered into a Stock Purchase Agreement to acquire all outstanding shares of Harvest Technologies Corporation, an innovative biotechnology company working to commercialize the world’s first point-of-care technology that allows physicians to derive highly concentrated autologous, adult stem cells from their patients in just 15 minutes.